• Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints

Abbott increases quarterly dividend for 54th consecutive year

Simon Osuji by Simon Osuji
February 2, 2026
in Technology
0
Abbott increases quarterly dividend for 54th consecutive year
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

AbbottAbbott (NYSE: ABT) announced that its board of directors has increased the company’s quarterly common dividend to 63 cents per share, an increase of 6.8%. The company’s quarterly dividend payout has increased more than 70% since 2020.


This marks Abbott’s 54th consecutive year of dividend growth and is the 408th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Feb. 13, 2026, to shareholders of record at the close of business on Jan. 15, 2026.

Related posts

Sanofi to pour more than $20B into US drug research and manufacturing

Sanofi drug, inherited from Genzyme, goes 1-for-2 in rare disease trials

February 2, 2026
World Wetlands Day: Integrating traditional knowledge in sustaining wetland ecosystems – EnviroNews

World Wetlands Day: Integrating traditional knowledge in sustaining wetland ecosystems – EnviroNews

February 2, 2026


Abbott is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.

About Abbott

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.

Source link

Previous Post

ICE and Qatari Security Forces at the Winter Olympics Put Italians on Edge

Next Post

Klarna backs Google UCP to power AI agent payments

Next Post
Klarna backs Google UCP to power AI agent payments

Klarna backs Google UCP to power AI agent payments

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

How to Take Advantage of the Samsung Free TV Promotion (2024)

How to Take Advantage of the Samsung Free TV Promotion (2024)

2 years ago
Cancer drugmaker LaNova to sell to China’s Sino Biopharm

Cancer drugmaker LaNova to sell to China’s Sino Biopharm

7 months ago
San Francisco Mayor Daniel Lurie: Past Leaders Took the City ‘for Granted’

San Francisco Mayor Daniel Lurie: Past Leaders Took the City ‘for Granted’

2 months ago
Dreamfarm, a startup out of Italy’s Food Valley, is setting its sights on the perfect vegan mozzarella

Dreamfarm, a startup out of Italy’s Food Valley, is setting its sights on the perfect vegan mozzarella

2 years ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0
  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0
  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0
  • Global ranking of Top 5 smartphone brands in Q3, 2024

    0 shares
    Share 0 Tweet 0
  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0

Get strategic intelligence you won’t find anywhere else. Subscribe to the Limitless Beliefs Newsletter for monthly insights on overlooked business opportunities across Africa.

Subscription Form

© 2026 LBNN – All rights reserved.

Privacy Policy | About Us | Contact

Tiktok Youtube Telegram Instagram Linkedin X-twitter
No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Fashion Intelligence

© 2023 LBNN - All rights reserved.